Nuclear Factor of Activated T Cells and Cytokines Gene Expression of the T Cells in AIDS Patients with Immune Reconstitution Inflammatory Syndrome during Highly Active Antiretroviral Therapy

Table 1

General information of the 63 AIDS patients enrolled in this study.

	IRIS (30 cases)	Non-IRIS (33 cases)
Gender
Male	28	30	>0.05
Female	2	3	>0.05
Average age	40.5	35.8	>0.05
CD4^+ T (cells/mm^3)
Pretreatment	45	150	<0.001
1-Month treatment	135	295	>0.05
HIV-RNA (log 10 copies/mL)
Pretreatment	5.52	5.627	>0.05
1-Month treatment	4.22	5.36	>0.05
Hemoglobin (g/dL)
Pretreatment; Mean duration of IRIS (days)	11.5; 31	13.6; /	>0.05
Therapeutic strategy
2NRTI + NNRTI	27	30	>0.05
2NRTI + PI	3	3	>0.05

NRTI: nucleoside reverse transcriptase inhibitors; NNRTI: nonnucleoside reverse transcriptase inhibitors; PI: protease inhibitor.